The StemSpine procedure uses AlloStem, which creates cells from a patient’s own bone marrow, according to a May 18 company news release.
The study found the StemSpine procedure led to a 90 percent or greater reduction in narcotics usage, a more than 80 percent reduction in pain score and more than 50 percent reduction in the Oswestry Score. No patients in the study needed surgical intervention, and there were no safety-related concerns.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
